ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

$15.21

0.12%

Market Cap: $17.9M

0

Funds holding %

of 6,710 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

3.02% less ownership

Funds ownership: 11.81% [Q1] → 8.79% (-3.02%) [Q2]

25% less funds holding

Funds holding: 16 [Q1] → 12 (-4) [Q2]

46% less capital invested

Capital invested by funds: $2.61M [Q1] → $1.4M (-$1.21M) [Q2]

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for CNCR.

See Analyst Rankings

Financial journalist opinion

Zacks Investment Research

5 ETFs That Led the Rebound on Monday

Wall Street roars back from its biggest weekly losses of the year, driven by bargain hunting and looming Fed rate cuts.

5 ETFs That Led the Rebound on Monday

Zacks Investment Research

Best-Performing ETF Areas of Past Week

Wall Street was upbeat last week on Fed rate cut hopes.

Best-Performing ETF Areas of Past Week

Zacks Investment Research

5 Top-Ranked ETFs to Buy at a Bargain

After a three-day rout, Wall Street staged a solid comeback as investors bought beaten-down stocks and recession fears eased. To tap the beaten-down prices, we have highlighted five ETFs from different corners that have declined over the past week and have a solid Zacks ETF Rank.

5 Top-Ranked ETFs to Buy at a Bargain

Zacks Investment Research

Best ETFs of Last Week

Wall Street offered a mixed performance last week.

Best ETFs of Last Week

Zacks Investment Research

5 Top ETFs of Last Week

Wall Street was moderately upbeat last week with the S&P 500, the Dow Jones and the Nasdaq gaining 0.87%, 1.6% and 0.3%, respectively. However, the small-cap index – the Russell 2000 – has advanced 6% as consumer inflation print came in at cooler-than-expected.

5 Top ETFs of Last Week

Last Week in ETFs: 8 New Defined Outcome ETFs Debut

Last week was a busy one for ETFs, with nine new ETFs launching on the first day of the week alone. Calamos, Innovator, AllianzIM, Direxion, Global X and ProShares were among the issuers rolling out new funds.

Last Week in ETFs: 8 New Defined Outcome ETFs Debut

Zacks Investment Research

3 Top-Ranked ETFs Under $20 for Your Portfolio

Low-priced stocks could be attractive as these will enable them to buy more shares instead of just a handful of higher-priced shares for the same amount.

3 Top-Ranked ETFs Under $20 for Your Portfolio

Zacks Investment Research

Best ETF Areas of Last Week

Wall Street was upbeat last week. The Fed's plan to slower the balance sheet tightening process and the release of downbeat jobs data dragged down bond yields.

Best ETF Areas of Last Week

Zacks Investment Research

5 Market-Beating Sector ETFs of Q1

Wall Street is set to wrap up the first quarter with strong gains. The gains were broad-based and well spread out across various segments.

5 Market-Beating Sector ETFs of Q1

Zacks Investment Research

Top & Flop ETF Areas of Wall Street's Best February in Decade

Wall Street surged to close out February with the S&P 500 and Nasdaq Composite notching their best February since 2015.

Top & Flop ETF Areas of Wall Street's Best February in Decade

See News Rankings